Veru (VERU)

• Market cap: $45.1M
• 1 day: 2.93%
• 5 days: 15.16%
• 1 month: -32.13%
• 3 months: -17.6%
• 6 months: -45.54%
• Year to date: -56.9%
• 1 year: -54.31%
• 5 years: -89.78%
• 10 years: -81.14%
• Sector: Healthcare
• Industry: Biotechnology

About: Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.

Employees: 210